Ligand
also invests · investor profile1 known investors
Ligand is a royalty aggregator that provides strategic capital to biopharmaceutical companies to finance and advance late-stage clinical development programs. It manages a diversified portfolio of over 200 commercial, clinical, and preclinical-stage biopharmaceutical royalty assets across multiple therapeutic areas.
BiotechFintech
Investors · 1
Acquisitions · 1
Early investors' stakes continue via these dealsXOMA Royalty
Biopharma royalty company acquired by Ligand, adding seven commercial products and more than 100 additional programs.
Frequently asked questions
- What does Ligand do?
- Ligand is a royalty aggregator that provides strategic capital to biopharmaceutical companies to finance and advance late-stage clinical development programs. It manages a diversified portfolio of over 200 commercial, clinical, and preclinical-stage biopharmaceutical royalty assets across multiple therapeutic areas.
- Who are Ligand's investors?
- Ligand's investors include Signet Healthcare Partners.